Efficiently Reversing Immunotherapy Resistance in Lung Cancer by an Inhalable 2D Molybdenum Disulfide T Cell Hyperactivation Platform
ACS Nano · 2025
DOI: 10.1021/acsnano.5c10202 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Yanze Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine (IMM), Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, Shanghai Jiao Tong Univer…. Hauptthemen laut MEDLINE: Lung Neoplasms, Disulfides, Immunotherapy, Molybdenum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, Agence Nationale de la Recherche, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Medicine (IMM), Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of MedicineTongji University, Shanghai 200433, China.
- Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
- CNRS, Immunology Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg 67000, France.
ORCID-Profile: Alberto Bianco, Ding-Kun Ji
Förderung
- Natural Science Foundation of Shanghai Municipality
- Agence Nationale de la Recherche
- National Key Research and Development Program of China
- Centre National de la Recherche Scientifique
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Yin, Y., Yang, C., Chen, Z., Du, H., Jiang, G., Bianco, A., Dai, J., & Ji, D. K. (2025). Efficiently Reversing Immunotherapy Resistance in Lung Cancer by an Inhalable 2D Molybdenum Disulfide T Cell Hyperactivation Platform. ACS Nano. https://doi.org/10.1021/acsnano.5c10202
Vancouver
Yin Y, Yang C, Chen Z, Du H, Jiang G, Bianco A, et al. Efficiently Reversing Immunotherapy Resistance in Lung Cancer by an Inhalable 2D Molybdenum Disulfide T Cell Hyperactivation Platform. ACS Nano. 2025. doi:10.1021/acsnano.5c10202
BibTeX
@article{Yin2025,
author = {Yin, Yanze and Yang, Changjie and Chen, Zhimin and Du, Han and Jiang, Gening and Bianco, Alberto and Dai, Jie and Ji, Ding-Kun},
title = {Efficiently Reversing Immunotherapy Resistance in Lung Cancer by an Inhalable 2D Molybdenum Disulfide T Cell Hyperactivation Platform},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.5c10202}
}
EUVIMED